The Canadian Medical Association is facing criticism over its decision to team up with a major pharmaceutical company to create an education program for physicians across the country.Click here to access this article. Hat tip to Capsules!
Some members of the medical community say the CMA is heading down a dangerous road and warn that partnering with Pfizer Canada Inc. may cross a serious ethical line that could negatively influence doctors' treatment decisions.
Under the new CMA initiative, Pfizer Canada said it will provide $780,000 to fund the new “continuing medical education” or CME program, designed to inform physicians of new developments in medicine and help maintain their skills. Two Pfizer staff members will also sit on an administrative board, responsible for overseeing, implementing and evaluating the program, along with two staff members from the medical association and two individuals from outside organizations.
The program will be offered online and will focus on 12 different subjects. The first, expected to be made available early next year, will focus on Parkinson's disease. Other topics will be determined based on gaps identified by physicians in surveys posted on the CMA website.
Friday, December 04, 2009
Canadian Medical Association criticized for accepting pharma funding
From the Globe and Mail article